https://exp-cancertherapy.med.tum.de/endaily1.0 https://exp-cancertherapy.med.tum.de/en/personen2023-04-03T14:58Zyearly https://exp-cancertherapy.med.tum.de/en/fak/research2019-10-29T14:48Znever https://exp-cancertherapy.med.tum.de/en/site/modelling-and-targeting-pancreatic-cancer2020-09-03T21:39Znever https://exp-cancertherapy.med.tum.de/en/seminar-series-translational-oncology2021-09-30T15:25Zyearly https://exp-cancertherapy.med.tum.de/en/publications/tissue-specific-tumorigenesis-context-matters2020-03-15T16:18Znever0.3 https://exp-cancertherapy.med.tum.de/en/publications/deciphering-universe-genetic-context-dependencies-using-mouse-models-cancer2020-03-15T16:13Znever0.3 https://exp-cancertherapy.med.tum.de/en/publications/evolutionary-routes-and-kras-dosage-define-pancreatic-cancer-phenotypes2020-03-15T16:14Znever0.3 https://exp-cancertherapy.med.tum.de/en/publications/next-generation-dual-recombinase-system-time-and-host-specific-targeting-pancreatic2020-03-15T16:16Znever0.3 https://exp-cancertherapy.med.tum.de/en/publications/selective-requirement-pi3kpdk1-signaling-kras-oncogene-driven-pancreatic-cell2020-03-15T16:17Znever0.3 https://exp-cancertherapy.med.tum.de/en/home2022-11-16T07:58Zyearly1.0 https://exp-cancertherapy.med.tum.de/en/publications/personalizing-kras-mutant-allele-specific-therapies2020-07-28T17:00Znever0.3 https://exp-cancertherapy.med.tum.de/en/publications/blocking-road-de-differentiation-hnf1akdm6a-complex-safeguards-epithelial-integrity2020-07-28T17:01Znever0.3 https://exp-cancertherapy.med.tum.de/en/publications/artificial-intelligence-early-drug-discovery-enabling-precision-medicine2021-06-30T21:27Zyearly0.3 https://exp-cancertherapy.med.tum.de/en/genetic-screens-identify-context-specific-pi3kp27kip1-node-driving-extrahepatic-biliary-cancer2021-09-30T15:17Zyearly0.3 https://exp-cancertherapy.med.tum.de/en/microbiota-and-colorectal-cancer-gut-bedside2021-09-30T15:18Zyearly0.3 https://exp-cancertherapy.med.tum.de/en/selective-multi-kinase-inhibition-sensitizes-mesenchymal-pancreatic-cancer-immune-checkpoint2023-03-31T13:16Zyearly0.3 https://exp-cancertherapy.med.tum.de/en/identification-treatment-induced-vulnerabilities-pancreatic-cancer-patients-using-functional-model2022-02-08T22:35Zyearly0.3 https://exp-cancertherapy.med.tum.de/en/single-cell-profiling-explore-pancreatic-cancer-heterogeneity-plasticity-and-response-therapy2023-03-31T13:14Zmonthly0.3 https://exp-cancertherapy.med.tum.de/en/self-renewal-equality-pancreas-homeostasis-regeneration-and-cancer2023-03-31T13:15Zmonthly0.3 https://exp-cancertherapy.med.tum.de/en/syngeneic-mouse-orthotopic-allografts-model-pancreatic-cancer2023-03-31T13:14Zmonthly0.3 https://exp-cancertherapy.med.tum.de/en/ap1fra1-confers-resistance-mapk-cascade-inhibition-pancreatic-cancer2023-03-31T13:08Zmonthly0.3 https://exp-cancertherapy.med.tum.de/en/context-specific-determinants-immunosuppressive-tumor-microenvironment-pancreatic-cancer2023-03-31T13:10Zmonthly0.3 https://exp-cancertherapy.med.tum.de/en/non-canonical-functions-snail-drive-context-specific-cancer-progression2023-03-31T13:12Zmonthly0.3 https://exp-cancertherapy.med.tum.de/en/cell-selective-proteomics-segregates-pancreatic-cancer-subtypes-extracellular-proteins-tumors-and2023-05-15T11:50Zdaily0.3 https://exp-cancertherapy.med.tum.de/de/impressum2021-07-21T11:48Znever0.2 https://exp-cancertherapy.med.tum.de/de/datenschutz2021-07-21T11:46Znever0.2